In 1921, insulin therapy changed diabetes from a near-certain death sentence into a treatable disease.
The discovery did not happen through a single lucky experiment. It came from decades of confusing pancreas research, failed animal extracts, surgical experiments on dogs, and a difficult purification problem that scientists had struggled with for years.
Photograph of Nobel Laureate F. G. Banting
The key breakthrough came when Canadian surgeon Frederick Banting worked with medical student Charles Best at the University of Toronto. They managed to isolate a pancreatic substance that lowered blood sugar in diabetic dogs without immediately poisoning them. That substance became insulin.
The story is fascinating partly because the science was messy. Researchers already knew the pancreas mattered. They just could not extract the right chemical safely enough to use as medicine.
Why Diabetes Was So Deadly Before Insulin
Before insulin therapy, Type 1 diabetes was usually fatal.
Doctors understood some of the symptoms:
- extreme thirst
- rapid weight loss
- sugar in urine
- exhaustion
- eventual coma
What they did not fully understand was the hormone system behind it.
The body constantly regulates glucose in the bloodstream. Cells need glucose for energy, but glucose cannot efficiently enter many cells without insulin signaling. In Type 1 diabetes, the immune system destroys the insulin-producing beta cells inside the pancreas.
Without insulin:
- blood glucose rises dangerously high
- cells become starved for usable energy
- the liver overproduces glucose
- fat breakdown accelerates
- acidic ketones build up in the blood
This can lead to diabetic ketoacidosis, which was almost always deadly before modern treatment.
Doctors sometimes used starvation diets to prolong life. Patients, including children, were given extremely low-calorie meals with minimal carbohydrates. These diets occasionally bought a few extra months or years, but many patients became severely malnourished.
Scientists Already Suspected The Pancreas
The insulin discovery story did not begin with Banting.
Several earlier researchers had already linked diabetes to the pancreas decades earlier.
In 1889, German researchers Oskar Minkowski and Joseph von Mering removed the pancreas from dogs. The animals quickly developed severe diabetes symptoms.
That experiment proved the pancreas was essential for blood sugar control.
The problem was that the pancreas has two very different jobs at the same time:
| Pancreas Function | Purpose |
|---|---|
| Exocrine function | Produces digestive enzymes |
| Endocrine function | Produces hormones like insulin |
This created a huge technical challenge.
When researchers tried grinding up pancreatic tissue to make extracts, the digestive enzymes often destroyed proteins inside the mixture. The extracts were toxic, inconsistent, or ineffective.
Scientists were trying to isolate a fragile hormone from an organ filled with powerful digestive chemicals. That is much harder than it sounds.
The Islets Of Langerhans Became The Key Clue
In 1869, medical student Paul Langerhans identified tiny clusters of unusual cells inside the pancreas.
These clusters were later named the Islets of Langerhans.
Researchers eventually suspected these islets produced the mysterious anti-diabetic substance.
Today we know the islets contain several endocrine cell types:
| Cell Type | Hormone Produced |
|---|---|
| Beta cells | Insulin |
| Alpha cells | Glucagon |
| Delta cells | Somatostatin |
At the time, though, scientists did not yet know insulin’s exact molecular structure or signaling mechanism. They only knew something inside the pancreas seemed capable of controlling blood sugar.
Banting’s Idea Came From A Surgical Observation
In late 1920, Banting was reading research papers on the pancreas while preparing a lecture.
One paper discussed what happened when pancreatic ducts were blocked.
That detail mattered because digestive enzymes travel through pancreatic ducts. If the ducts are tied off, the enzyme-producing tissue begins to degenerate. The endocrine islet cells survive longer.
Banting wondered whether this could solve the extraction problem.
His idea was surprisingly practical:
- tie off pancreatic ducts in dogs
- wait for digestive tissue to shrink
- isolate the remaining endocrine tissue
- prepare an extract with fewer destructive enzymes
It was not a complete theory of diabetes. It was more like a surgical workaround for a biochemical problem.
Banting approached physiologist John James Rickard Macleod at the University of Toronto for lab space and support. Macleod was initially skeptical but eventually provided dogs, equipment, and assistance.
Banting then began working with Charles Best in the summer of 1921.
The Dog Experiments That Changed Medicine
The experiments were difficult and often chaotic.
The researchers operated on dogs, tied off pancreatic ducts, waited for tissue degeneration, and then prepared crude pancreatic extracts.
They induced diabetes in other dogs by removing the pancreas entirely.
When extracts from the treated pancreases were injected into diabetic dogs, something dramatic happened:
- blood glucose dropped
- urine sugar decreased
- symptoms temporarily improved
One diabetic dog named Marjorie survived for weeks on repeated injections. That was a major sign the extract was biologically active.
The team initially called the substance “isletin.” The name insulin later became standard, derived from the Latin word insula, meaning island, referring to the pancreatic islets.
The Biggest Problem Was Purification
Lowering blood sugar in dogs was not enough.
The extracts were still impure and dangerous.
Early pancreatic mixtures contained:
- proteins
- digestive enzymes
- contaminants
- degraded biological material
Injecting crude extracts into humans could cause fever, abscesses, allergic reactions, or toxicity.
This is where biochemist James Collip became critical to the project.
Collip joined the team in late 1921 and focused heavily on purification chemistry. He used alcohol extraction methods to separate insulin from many unwanted substances.
That purification work is sometimes overshadowed in popular retellings, but it was essential. Discovering a biologically active compound is only part of medicine development. Producing it safely and consistently is often the harder challenge.
The First Human Insulin Treatment
In January 1922, a 14-year-old boy named Leonard Thompson became the first human patient treated with insulin.
He had severe Type 1 diabetes and was close to death.
The first injection was only partially successful because impurities caused side effects. Collip rapidly improved the purification process, and a second injection worked far better.
Leonard’s blood glucose dropped significantly.
Ketones decreased.
His condition improved.
For doctors watching this happen in real time, it must have felt almost unbelievable. Children dying from diabetes were suddenly recovering strength, gaining weight, and surviving.
Hospitals soon reported dramatic transformations in diabetic wards.
Why Insulin Was Different From Earlier Treatments
Insulin therapy worked because it treated the underlying hormone deficiency instead of merely controlling symptoms.
That distinction mattered enormously.
Earlier diabetes treatments mostly focused on restricting food intake. Insulin addressed the missing biochemical signal itself.
Modern physiology now explains insulin’s role in much greater detail.
Insulin helps regulate:
- glucose uptake into muscle and fat cells
- glycogen synthesis in the liver
- fat metabolism
- protein synthesis
- ketone suppression
At the cellular level, insulin binds to insulin receptors on cell membranes and activates signaling pathways involving phosphorylation cascades and glucose transporter movement, especially GLUT4 transporters in muscle and adipose tissue.
None of this signaling biology was understood in 1921. Researchers only observed the physiological effects.
There Was Serious Debate Over Credit
The insulin story also became controversial.
In 1923, the Nobel Prize in Physiology or Medicine was awarded to Banting and Macleod.
Photograph of Nobel Laureate J.J.R._Macleod_ca._1928
Banting was furious that Best was excluded. He shared part of his prize money with Best. Macleod shared his portion with Collip.
Historians still debate how credit should be distributed.
Different people contributed different things:
| Researcher | Major Contribution |
|---|---|
| Banting | Initial experimental idea |
| Best | Experimental assistance and measurements |
| Macleod | Laboratory support and scientific oversight |
| Collip | Purification chemistry |
There were also earlier researchers, including Romanian physiologist Nicolae Paulescu, who had produced pancreatic extracts before Banting’s team. Paulescu demonstrated anti-diabetic effects in dogs before 1921, though his preparations were not successfully developed into clinical therapy.
This remains an important historical discussion because scientific discoveries are often collaborative and incremental rather than single moments of genius.
Early Insulin Came From Animal Pancreases
After insulin proved effective, production scaled rapidly.
Early commercial insulin was extracted mainly from:
- pig pancreases
- cow pancreases
Large slaughterhouses became important raw material sources.
Animal insulin saved millions of lives, but it had limitations:
- purity variability
- allergic reactions in some patients
- supply constraints
- shorter duration of action
Manufacturing required enormous numbers of animal organs. Producing insulin at industrial scale became a major biochemical engineering challenge.
Companies refined extraction and purification methods throughout the 20th century.
Recombinant Human Insulin Changed Everything Again
A second major insulin revolution happened decades later.
In 1978, scientists successfully used recombinant DNA technology to produce human insulin in genetically modified bacteria.
This was one of the earliest major biotechnology medicines.
Instead of extracting insulin from animals, researchers inserted the human insulin gene into microorganisms such as Escherichia coli.
The engineered bacteria produced insulin proteins that could be purified industrially.
In 1982, recombinant human insulin became commercially available.
That shift improved:
- consistency
- purity
- scalability
- patient compatibility
Modern insulin engineering has since expanded into rapid-acting insulin analogs, long-acting formulations, insulin pumps, and closed-loop glucose control systems.
Insulin Discovery Also Changed Modern Medicine
The insulin story influenced far more than diabetes treatment.
It helped establish:
- hormone biology as a major scientific field
- large-scale biopharmaceutical manufacturing
- modern endocrinology
- protein purification techniques
- biotechnology medicine development
It also changed public expectations about disease treatment. Before insulin, many chronic illnesses had few effective therapies. Insulin showed that replacing missing biological molecules could transform survival.
That idea later influenced treatments involving hormones, enzymes, antibodies, and recombinant proteins.
A Discovery Built From Biology, Surgery, And Chemistry
One reason the insulin story still feels compelling is that it was not purely theoretical science.
The breakthrough depended on several different kinds of knowledge working together:
- surgical techniques
- animal physiology
- pancreatic anatomy
- protein chemistry
- industrial manufacturing
- clinical medicine
Even the famous “duct tying” experiment was really an engineering-style workaround to isolate a delicate biological signal from destructive surrounding tissue.
The science behind insulin is now vastly more advanced than it was in 1921. Researchers understand insulin receptors, molecular structures, autoimmune beta-cell destruction, glucose transport systems, and gene-engineered insulin production in extraordinary detail.
Still, the core moment remains surprisingly human.
A young doctor noticed a detail in a research paper late at night and asked a difficult question nobody had fully solved yet.
That question ended up saving millions of lives.
